107 related articles for article (PubMed ID: 35147991)
1. Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers.
Nishijima TF; Deal AM; Williams GR; Sanoff HK; Nyrop KA; Muss HB
Cancer; 2022 May; 128(10):1929-1936. PubMed ID: 35147991
[TBL] [Abstract][Full Text] [Related]
2. Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study.
Ostwal V; Ramaswamy A; Bhargava P; Hatkhambkar T; Swami R; Rastogi S; Mandavkar S; Ghosh J; Bajpai J; Gulia S; Srinivas S; Rath S; Gupta S
BMJ Open; 2021 Jun; 11(6):e047376. PubMed ID: 34187825
[TBL] [Abstract][Full Text] [Related]
3. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy Toxicity Risk Score for Treatment Decisions in Older Adults with Advanced Solid Tumors.
Nishijima TF; Deal AM; Williams GR; Sanoff HK; Nyrop KA; Muss HB
Oncologist; 2018 May; 23(5):573-579. PubMed ID: 29371477
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.
Chan WL; Ma T; Cheung KL; Choi H; Wong J; Lam KO; Yuen KK; Luk MY; Kwong D
J Geriatr Oncol; 2021 May; 12(4):557-562. PubMed ID: 33127385
[TBL] [Abstract][Full Text] [Related]
6. Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancer.
Alibhai SMH; Breunis H; Hansen AR; Gregg R; Warde P; Timilshina N; Tomlinson G; Joshua AM; Hotte S; Fleshner N; Emmenegger U
Cancer; 2021 Jul; 127(14):2587-2594. PubMed ID: 33798267
[TBL] [Abstract][Full Text] [Related]
7. Assessing the ability of the Cancer and Aging Research Group tool to predict chemotherapy toxicity in older Japanese patients: A prospective observational study.
Uchiyama M; Miyazaki M; Hayashi T; Shimokawa M; Nakano T; Kakimoto H; Takaki S; Fukue H; Inoue T; Inoue R; Mashima K; Kawata S; Sumi Y; Igarashi Y; Kamimura H; Imakyure O; Matsuo K
J Geriatr Oncol; 2024 Jun; 15(6):101814. PubMed ID: 38851083
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer.
Alibhai SM; Aziz S; Manokumar T; Timilshina N; Breunis H
J Geriatr Oncol; 2017 Jan; 8(1):31-36. PubMed ID: 27756545
[TBL] [Abstract][Full Text] [Related]
9. Association between chemotherapy toxicity risk scores and physical symptoms among older Brazilian adults with cancer.
Bergerot CD; Razavi M; Philip EJ; Bergerot PG; Soto-Perez-de-Celis E; De Domenico EBL; Clark KL; Loscalzo M; Pal SK; Dale W
J Geriatr Oncol; 2020 Mar; 11(2):280-283. PubMed ID: 31401205
[TBL] [Abstract][Full Text] [Related]
10. Use of the Cancer and Aging Research Group Predictive Model for Chemotherapy-Related Toxic Effects in a Multiethnic, Older Adult Asian Population.
Pang A; Jiali L; Ng A; Cheng J; Wang M; Ng YS; Yao Y; Chun M; Ho F; Tey J
JAMA Netw Open; 2022 Oct; 5(10):e2237196. PubMed ID: 36255721
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
[TBL] [Abstract][Full Text] [Related]
12. Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer.
Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
J Geriatr Oncol; 2019 Mar; 10(2):210-215. PubMed ID: 30503312
[TBL] [Abstract][Full Text] [Related]
13. Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer.
Ortland I; Mendel Ott M; Kowar M; Sippel C; Jaehde U; Jacobs AH; Ko YD
J Geriatr Oncol; 2020 Jul; 11(6):997-1005. PubMed ID: 31928942
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the Index4 tool for chemotherapy toxicity prediction in cancer patients older than 70 years old.
Lewis A; Reed M; Walde N; Voutsadakis IA
Sci Rep; 2023 Jan; 13(1):1082. PubMed ID: 36658198
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST).
Den Hollander D; Van der Graaf WTA; Desar IME; Le Cesne A
Acta Oncol; 2019 Nov; 58(11):1648-1654. PubMed ID: 31345082
[No Abstract] [Full Text] [Related]
16. Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study.
Fanotto V; Fornaro L; Bordonaro R; Rosati G; Rimassa L; Di Donato S; Santini D; Tomasello G; Leone F; Silvestris N; Stragliotto S; Scartozzi M; Giampieri R; Nichetti F; Antonuzzo L; Cinieri S; Avallone A; Pellegrino A; Melisi D; Vasile E; Gerratana L; Aprile G
J Geriatr Oncol; 2019 Jul; 10(4):591-597. PubMed ID: 30551958
[TBL] [Abstract][Full Text] [Related]
17. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.
Mariano C; Jamal R; Bains P; Hejazi S; Chao L; Wan J; Ho J
Curr Oncol; 2019 Aug; 26(4):234-239. PubMed ID: 31548802
[TBL] [Abstract][Full Text] [Related]
18. External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort.
Frelaut M; Paillaud E; Beinse G; Scain AL; Culine S; Tournigand C; Poisson J; Bastuji-Garin S; Canoui-Poitrine F; Caillet P
Oncologist; 2023 Jun; 28(6):e341-e349. PubMed ID: 37027521
[TBL] [Abstract][Full Text] [Related]
19. Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy.
Fan KY; Lalani N; LeVasseur N; Krauze A; Hsu F; Gondara L; Willemsma K; Nichol AM
J Neurooncol; 2021 Jan; 151(2):231-240. PubMed ID: 33206309
[TBL] [Abstract][Full Text] [Related]
20. Predicting Chemotherapy-Related Adverse Events in Elderly Cancer Patients with Prior Anticancer Therapy.
Suto H; Inui Y; Okamura A
Curr Oncol; 2022 Mar; 29(4):2185-2192. PubMed ID: 35448151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
